Loading institutional data...
Loading institutional data...
Institutional accumulation: ownership increased +2.40% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $10.57 today, the market must believe free cash flow compounds -9.6%/yr for a decade (off $32M normalized FCF).
The market's -9.6% is more conservative than its 6-yr track record.
2-stage DCF · 0.02B shares · net debt -$15M
mean 132.3% · volatility σ 461% · implied rate exceeded in 2/4 yrs
Central path = implied -9.6%/yr growth; shaded band = ±1σ (461%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $789.8M 100.0% | $757.4M 100.0% | $717.7M 100.0% | $683.1M 100.0% | $650.3M 100.0% | $540.8M 100.0% | $535.8M 100.0% | $472.8M 100.0% | $427.5M 100.0% | $422.1M 100.0% |
| Cost of Revenue | $629.9M 79.8% | $603.5M 79.7% | $585.1M 81.5% | $569.1M 83.3% | $532.4M 81.9% | $431.3M 79.8% | $417.4M 77.9% | $383.6M 81.1% | $320.5M 75.0% | $305.2M 72.3% |
| Gross Profit | $159.9M 20.2% | $153.8M 20.3% | $132.6M 18.5% | $114.0M 16.7% | $117.9M 18.1% | $109.5M 20.2% | $118.4M 22.1% | $89.2M 18.9% | $107.0M 25.0% | $116.9M 27.7% |
| Research & Development | $14.2M 1.8% | $11.4M 1.5% | $10.0M 1.4% | $10.3M 1.5% | $10.5M 1.6% | $8.6M 1.6% | $9.2M 1.7% | $8.0M 1.7% | $5.7M 1.3% | $3.8M 0.9% |
| Selling, General & Admin | $63.3M 8.0% | $64.0M 8.5% | $57.8M 8.0% | $54.8M 8.0% | $57.5M 8.8% | $53.8M 10.0% | $53.2M 9.9% | $45.0M 9.5% | $35.5M 8.3% | $31.1M 7.4% |
| Total Operating Expenses | $94.1M 11.9% | $113.9M 15.0% | $86.4M 12.0% | $77.5M 11.3% | $89.2M 13.7% | $62.8M 11.6% | $101.7M 19.0% | $73.5M 15.6% | $56.2M 13.1% | $47.1M 11.2% |
| Operating Income | $65.8M 8.3% | $39.9M 5.3% | $46.1M 6.4% | $36.4M 5.3% | $28.7M 4.4% | $46.6M 8.6% | $16.7M 3.1% | $15.6M 3.3% | $50.8M 11.9% | $69.8M 16.5% |
| Other Income (Expense), net | -$45.6M -5.8% | -$55.6M -7.3% | -$59.2M -8.2% | -$39.6M -5.8% | -$15.6M -2.4% | — | — | — | — | — |
| Pretax Income | $20.3M 2.6% | -$15.7M -2.1% | -$13.1M -1.8% | -$3.1M -0.5% | $13.1M 2.0% | $30.9M 5.7% | -$8.3M -1.5% | -$7.6M -1.6% | $35.4M 8.3% | $56.7M 13.4% |
| Income Tax Expense | $7.9M 1.0% | $3.8M 0.5% | $36.2M 5.0% | $1.1M 0.2% | $5.8M 0.9% | $9.4M 1.7% | -$1.0M -0.2% | $268K 0.1% | $16.1M 3.8% | $18.0M 4.3% |
| Net Income | $12.0M 1.5% | -$19.0M -2.5% | -$49.0M -6.8% | -$4.0M -0.6% | $7.0M 1.1% | $21.5M 4.0% | -$7.3M -1.4% | -$7.8M -1.7% | $19.3M 4.5% | $38.7M 9.2% |
| Per Share | ||||||||||
| EPS (Basic) | $0.64 | $-0.99 | $-2.51 | $-0.22 | $0.38 | $1.13 | $-0.39 | $-0.42 | $1.02 | $2.08 |
| EPS (Diluted) | $0.62 | $-0.99 | $-2.51 | $-0.22 | $0.38 | $1.11 | $-0.39 | $-0.42 | $0.99 | $1.99 |
| Weighted Avg Shares (Basic) | 19.3M | 19.7M | 19.6M | 19.3M | 19.1M | 19.0M | 18.9M | 18.8M | 18.9M | 18.6M |
| Weighted Avg Shares (Diluted) | 20.0M | 19.7M | 19.6M | 19.3M | 19.6M | 19.4M | 18.9M | 18.8M | 19.5M | 19.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $11M buybacks = $11M returned on $15M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 5%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 15-yr range · 16th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 15.1× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 81.1 | 77.9 | 79.8 | 81.9 | 83.3 | 81.5 | 79.7 | 79.8 |
| Gross Profit | 18.9 | 22.1 | 20.2 | 18.1 | 16.7 | 18.5 | 20.3 | 20.2 |
| R&D | 1.7 | 1.7 | 1.6 | 1.6 | 1.5 | 1.4 | 1.5 | 1.8 |
| SG&A | 9.5 | 9.9 | 10.0 | 8.8 | 8.0 | 8.0 | 8.5 | 8.0 |
| Operating Income | 3.3 | 3.1 | 8.6 | 4.4 | 5.3 | 6.4 | 5.3 | 8.3 |
| Income Tax | 0.1 | -0.2 | 1.7 | 0.9 | 0.2 | 5.0 | 0.5 | 1.0 |
| Net Income | -1.7 | -1.4 | 4.0 | 1.1 | -0.6 | -6.8 | -2.5 | 1.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MPAA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 490 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMZN | $2.65T | — | — | — | — | — | — | 20.5% | 16.2% | — | 5,764 |
| TSLA | $1.34T | 331.6× | 142.2× | 14.2× | -2.9% | 18.0% | 4.0% | 4.6% | 4.2% | 0.9× | 4,029 |
| TM | $608.8B | 59.5× | 24.6× | 2.6× | 3.8% | 18.4% | 4.4% | 7.9% | 5.9% | 1.7× | 665 |
| PDD | $448.4B | 33.4× | 32.3× | 7.3× | 14.5% | 56.3% | 22.7% | 23.7% | 23.7% | — | 548 |
| HD | $301.3B | 21.3× | 14.3× | 1.8× | 3.2% | 33.3% | 8.6% | 110% | 22.8% | 2.0× | 3,970 |
| BABA | $199.3B | 134.1× | — | 1.3× | 8.1% | 39.8% | 10.1% | 9.8% | 9.8% | — | 1,298 |
| TJX | $136.0B | 25.2× | — | 2.3× | 7.1% | 31.0% | 9.1% | 53.9% | 42.1% | — | 2,608 |
| HTHT | $131.2B | 185.7× | 113.0× | — | — | — | — | 39.7% | 27.3% | 0.7× | 258 |
| SBUX | $110.7B | 59.7× | 26.9× | 3.0× | 2.8% | — | 5.0% | -22.9% | 23.3% | 3.4× | 2,252 |
| LOW | $108.9B | 16.4× | 12.0× | 1.3× | 3.1% | 33.5% | 7.7% | -67.1% | 22.3% | 3.2× | 2,591 |
| ABNB | $102.7B | — | 38.3× | 8.4× | 10.3% | 83.0% | 20.5% | 30.6% | 24.6% | 0.8× | 1,246 |
| MELI | $93.3B | 46.7× | — | 3.2× | 39.1% | 44.5% | 6.9% | 29.6% | 12.5% | — | 1,380 |
| MAR | $89.1B | 35.2× | 20.7× | 3.4× | 4.3% | — | 9.9% | -69.0% | -69.4% | 0.0× | 1,559 |
| LKNCY | $87.3B | 170.2× | 91.9× | 12.4× | 48.9% | — | 7.3% | 23.0% | 23.0% | — | 9 |
| GM | $76.2B | 25.8× | 3.7× | 0.4× | -1.3% | — | 1.5% | 4.4% | 4.4% | — | 1,447 |
| ROST | $72.5B | 34.0× | 21.6× | 3.2× | 7.7% | 27.7% | 9.4% | 34.7% | 27.8% | 0.5× | 1,276 |
| ORLY | $70.5B | 28.2× | 19.2× | 4.0× | 6.4% | 51.6% | 14.3% | -333% | 48.3% | 1.5× | 1,569 |
| HLT | $70.4B | 49.9× | 24.2× | 5.8× | 7.7% | — | 12.1% | -27.0% | -27.0% | — | 1,126 |
| RCL | $68.8B | 16.3× | — | 3.8× | 8.8% | 49.4% | 23.8% | 42.5% | 32.3% | — | 1,114 |
| SE | $63.4B | 41.1× | 25.1× | 2.8× | 36.4% | 44.7% | 6.9% | 12.6% | 12.6% | — | 718 |
| F | $53.1B | — | 4.4× | 0.3× | 1.2% | 6.8% | -4.4% | -22.7% | -22.7% | — | — |
| NKE | $53.1B | 17.0× | — | 1.1× | 0.2% | 42.9% | 6.7% | 20.9% | 13.6% | — | 1,848 |
| EBAY | $49.0B | 25.1× | 17.8× | 4.4× | 7.9% | 71.5% | 18.3% | 45.3% | 38.8% | 0.3× | 1,182 |
| AZO | $47.8B | 19.7× | 13.3× | 2.5× | 2.4% | 52.6% | 13.2% | -73.2% | 46.4% | 2.1× | 1,245 |
| CMG | $45.0B | 29.5× | 19.4× | 3.8× | 5.4% | — | 12.9% | 54.3% | 54.3% | 0.0× | 1,203 |
| MPAA | $202M | 17.2× | 2.5× | 0.3× | 4.3% | 20.2% | 1.6% | 4.7% | 4.7% | — | 105 |
Peers = companies sharing MPAA's sector (Consumer Cyclical) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.